DDW’s Megan Thomas shines a spotlight on Richard Cuthbert, Global Product Manager at Bio-Rad Laboratories. This interview took place while attending ELRIG Drug Discovery 2024 in London, UK. MT: What has your career path looked like? Were there any key moments or milestones that led you to where you are today?… Read More
Bio-Rad Laboratories has launched validated antibodies for rare cell and circulating tumour cell (CTC) enumeration for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits. The antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of… Read More
DDW has published the latest addition to its Guide Series, ‘Where is the innovation and opportunity in the therapeutic antibody market and how is it evolving?’ It is sponsored by Bio-Rad Laboratories. In this free, exclusive guide, you will read: The future of therapeutic… Read More
This report will: Provide an overview of the monoclonal antibody (mAbs) industry: market value, key on the future of antibody-based drug players, opportunities and the future Explore what’s next for antibody-based drugs and where the opportunity is coming from Include an interview Bio-Rad’s… Read More
Created by DDW and sponsored by Bio-Rad, The future of antibody-based drugs: Where are the opportunities and what does the future hold? is a free In Focus report, available here. This report will: Provide an overview of the monoclonal… Read More
Cytek Biosciences and Bio-Rad Laboratories have entered into a strategic development partnership. Under the terms of the agreement, Bio-Rad’s new StarBright Dyes will be available to Cytek to develop and commercialise reagent products to support high-parameter applications on Aurora and Northern Lights flow cytometry systems. … Read More
